Our study provides the first evidence that AL513318.2 is highly expressed in NSCLC and negatively correlates with hsa-miR-26a-5p expression to regulate poor prognosis of SLC6A8 in NSCLC. Here, SLC6A8 is linked to non-small cell lung carcinoma.